Enovis’ Robust Global Footprint Drives Double-Digit Growth
The company grew in the low double digits in 1Q25 on the strength of new product introductions and robust international sales. May 16, 2025
Orthopedic Funding Off to Slower Start in 2025
Through the first four months of the year, orthopedic funding is off to its slowest start in the last decade. May 14, 2025
Vericel Opening New Opportunities with MACI Arthro
The company grew in the mid-teens and could see even greater demand with MACI Arthro's use for trochlea defects. May 14, 2025
Anika Drives Significant Growth in Commercial Channel
The company's orthopedic sales declined about 10% in the first quarter of 2025, but its commercial channel showed ample promise. May 13, 2025
Treace Medical Set Up for Big Second Half in 2025
The company grew in the low single digits for the first quarter of 2025 and expects accelerating growth through the year. May 13, 2025
Orthopedic Companies Report Results from First Quarter 2025
Stay up to date on the orthopedic market's 1Q performance in 2025 as we update this post with company sales data and industry developments. May 12, 2025
Globus Medical Slowed by Multiple Issues in First Quarter
The company faced market softness, supply issues and international order timing lumpiness as it declined in the low single digits. May 12, 2025
The State of Orthopedics in 2025
Takeaways, discussion and exhibits from the brand new 2025 edition of our ORTHOPAEDIC INDUSTRY ANNUAL REPORT. May 12, 2025
Bioventus Executes in Face of Challenging Comps and One-Time Items
The company's orthopedic sales grew 6% in the first quarter of 2025 on the strength of DUROLANE and Exogen. May 09, 2025
SI-BONE Starts Year Strong with Record Physician Base
The company grew nearly 25% in the first quarter of 2025 as its physician user base reached record levels. May 09, 2025
